Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma.

di Martino E, Hardie LJ, Wild CP, Gong YY, Olliver JR, Gough MD, Bird NC.

Genet Med. 2007 Jun;9(6):341-7.

PMID:
17575500
2.

Methylene blue but not indigo carmine causes DNA damage to colonocytes in vitro and in vivo at concentrations used in clinical chromoendoscopy.

Davies J, Burke D, Olliver JR, Hardie LJ, Wild CP, Routledge MN.

Gut. 2007 Jan;56(1):155-6. No abstract available.

3.

Risk factors, DNA damage, and disease progression in Barrett's esophagus.

Olliver JR, Hardie LJ, Gong Y, Dexter S, Chalmers D, Harris KM, Wild CP.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):620-5.

4.

DNA damage levels are raised in Barrett's oesophageal mucosa relative to the squamous epithelium of the oesophagus.

Olliver JR, Hardie LJ, Dexter S, Chalmers D, Wild CP.

Biomarkers. 2003 Nov-Dec;8(6):509-21.

PMID:
15195681
5.

Chromoendoscopy with methylene blue and the risk of DNA damage.

Hardie LJ, Olliver JR, Wild CP, Dexter S, Sahay P.

Gastroenterology. 2004 Feb;126(2):623; author reply 623-4. No abstract available.

PMID:
14765394
6.

Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus.

Olliver JR, Wild CP, Sahay P, Dexter S, Hardie LJ.

Lancet. 2003 Aug 2;362(9381):373-4.

PMID:
12907012

Supplemental Content

Loading ...
Support Center